《MedRixv,3月1日,Prediction of survival for severe Covid-19 patients with three clinical features: development of a machine learning-based prognostic model with clinical data in Wuhan》

  • 来源专题:COVID-19科研动态监测
  • 编译者: zhangmin
  • 发布时间:2020-03-02
  • Prediction of survival for severe Covid-19 patients with three clinical features: development of a machine learning-based prognostic model with clinical data in Wuhan

    Li Yan, Hai-Tao Zhang, Yang Xiao, Maolin Wang, Chuan Sun, Jing Liang, Shusheng Li, Mingyang Zhang, Yuqi Guo, Ying Xiao, Xiuchuan Tang, Haosen Cao, Xi Tan, Niannian Huang, Bo Jiao, Ailin Luo, Zhiguo Cao, Hui Xu, Ye Yuan

    doi: https://doi.org/10.1101/2020.02.27.20028027

    Abstract

    The swift spread of COVID-19 epidemic has attracted worldwide attentions since Dec., 2019. Till date, 77,041 confirmed Chinese cases have been reported by National Health Commission of P.R. China with 9,126 critical cases whose survival rate is quite low. Meanwhile, COVID-19 epidemic emergence within the other countries (e.g., Korea, Italy, Japan and Iran) is also remarkable with the increasing spread speed. It plays a more and more important role to efficiently and precisely predict the survival rate for critically ill Covid-19 patients as more fatal cases can be targeted interfered in advanced.

    *注,本文为预印本论文手稿,是未经同行评审的初步报告,其观点仅供科研同行交流,并不是结论性内容,请使用者谨慎使用.

  • 原文来源:https://www.medrxiv.org/content/10.1101/2020.02.27.20028027v1
相关报告
  • 《MedRxiv,3月17日,(第3版更新)A machine learning-based model for survival prediction in patients with severe COVID-19 infection》

    • 来源专题:COVID-19科研动态监测
    • 编译者:zhangmin
    • 发布时间:2020-03-18
    • A machine learning-based model for survival prediction in patients with severe COVID-19 infection Li Yan, Hai-Tao Zhang, Jorge Goncalves, Yang Xiao, Maolin Wang, Yuqi Guo, Chuan Sun, Xiuchuan Tang, Liang Jin, Mingyang Zhang, Xiang Huang, Ying Xiao, Haosen Cao, Yanyan Chen, Tongxin Ren, Fang Wang, Yaru Xiao, Sufang Huang, Xi Tan, Niannian Huang, Bo Jiao, Yong Zhang, Ailin Luo, Laurent Mombaerts, Junyang Jin, Zhiguo Cao, Shusheng Li, Hui Xu, Ye Yuan doi: https://doi.org/10.1101/2020.02.27.20028027 Abstract The sudden increase of COVID-19 cases is putting a high pressure on healthcare services worldwide. At the current stage, fast, accurate and early clinical assessment of the disease severity is vital. To support decision making and logistical planning in healthcare systems, this study leverages a database of blood samples from 404 infected patients in the region of Wuhan, China to identify crucial predictive biomarkers of disease severity. For this purpose, machine learning tools selected three biomarkers that predict the survival of individual patients with more than 90% accuracy: lactic dehydrogenase (LDH), lymphocyte and high-sensitivity C-reactive protein (hs-CRP). *注,本文为预印本论文手稿,是未经同行评审的初步报告,其观点仅供科研同行交流,并不是结论性内容,请使用者谨慎使用.
  • 《Cell,8月3日,A Learning-based Model to Evaluate Hospitalization Priority in COVID-19 Pandemics》

    • 来源专题:COVID-19科研动态监测
    • 编译者:zhangmin
    • 发布时间:2020-08-19
    • A Learning-based Model to Evaluate Hospitalization Priority in COVID-19 Pandemics Yichao Zheng 5 Yinheng Zhu 5 Mengqi Ji Choo Hui Qin Lu Fang Shaohua Ma 6 Open AccessPublished:August 03, 2020DOI:https://doi.org/10.1016/j.patter.2020.100092 Summary The emergence of novel coronavirus disease 2019 (COVID-19) is placing an increasing burden on the healthcare systems. Although the majority of infected patients have non-severe symptoms and can be managed at home, some individuals may develop severe disease and are demanding the hospital admission. Therefore, it becomes paramount to efficiently assess the severity of COVID-19 and identify hospitalization priority with precision. In this respect, a 4-variable assessment model, including lymphocyte, lactate dehydrogenase (LDH), C-reactive protein (CRP) and neutrophil, is established and validated using the XGBoost algorithm. This model is found effective to identify severe COVID-19 cases on admission, with a sensitivity of 84.6%, a specificity of 84.6%, and an accuracy of 100% to predict the disease progression toward rapid deterioration. It also suggests that a computation-derived formula of clinical measures is practically applicable for the healthcare administrators to distribute hospitalization resources to the most needed in epidemics and pandemics.